<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC7449939/figure_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption> Comparison of the consumption of antibiotics used for the treatment of community-onset pneumonia pre-coronavirus disease 2019 (COVID-19) (blue bars) and during COVID-19 (orange bars). Defined daily doses (DDD) of antibiotics (ceftriaxone, co-amoxiclav, levofloxacin, moxifloxacin, azithromycin and clarithromycin) were higher in February and March during the onset of the COVID-19 pandemic. </caption>
 <div class="graphic"/>
 <p class="label">Fig. 1</p>
</div>
